To further evaluate RBM39 and PRMT6 expression patterns, immunohistochemistry of tumor sections indicated significant down-regulation of both proteins in the combination group relative to the DMSO, Indisulam, or MS023 groups (Fig 8I). Here, RBM39 is linked to neoplasm.